GB1357733A - 1,2,4-oxadiazole derivatives - Google Patents
1,2,4-oxadiazole derivativesInfo
- Publication number
- GB1357733A GB1357733A GB1227270A GB1227270A GB1357733A GB 1357733 A GB1357733 A GB 1357733A GB 1227270 A GB1227270 A GB 1227270A GB 1227270 A GB1227270 A GB 1227270A GB 1357733 A GB1357733 A GB 1357733A
- Authority
- GB
- United Kingdom
- Prior art keywords
- together form
- pharmaceutical compositions
- carbon bond
- carbon
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000005071 1,2,4-oxadiazoles Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 239000004098 Tetracycline Substances 0.000 abstract 1
- 125000004442 acylamino group Chemical group 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 230000002141 anti-parasite Effects 0.000 abstract 1
- 230000000840 anti-viral effect Effects 0.000 abstract 1
- 239000003096 antiparasitic agent Substances 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- VQODGRNSFPNSQE-DVTGEIKXSA-N betamethasone phosphate Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COP(O)(O)=O)(O)[C@@]1(C)C[C@@H]2O VQODGRNSFPNSQE-DVTGEIKXSA-N 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 abstract 1
- -1 hydroxy, carboxy Chemical group 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 abstract 1
- 125000001302 tertiary amino group Chemical group 0.000 abstract 1
- 229960002180 tetracycline Drugs 0.000 abstract 1
- 229930101283 tetracycline Natural products 0.000 abstract 1
- 235000019364 tetracycline Nutrition 0.000 abstract 1
- 150000003522 tetracyclines Chemical class 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
- C07D271/07—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1227270A GB1357733A (en) | 1970-07-28 | 1970-07-28 | 1,2,4-oxadiazole derivatives |
| FR7127409A FR2100958B1 (enExample) | 1970-07-28 | 1971-07-27 | |
| NL7110316A NL7110316A (enExample) | 1970-07-28 | 1971-07-27 | |
| CH1107071A CH579544A5 (enExample) | 1970-07-28 | 1971-07-27 | |
| DE19712137523 DE2137523A1 (de) | 1970-07-28 | 1971-07-27 | Oxadiazolderivate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1227270A GB1357733A (en) | 1970-07-28 | 1970-07-28 | 1,2,4-oxadiazole derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1357733A true GB1357733A (en) | 1974-06-26 |
Family
ID=10001510
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1227270A Expired GB1357733A (en) | 1970-07-28 | 1970-07-28 | 1,2,4-oxadiazole derivatives |
Country Status (5)
| Country | Link |
|---|---|
| CH (1) | CH579544A5 (enExample) |
| DE (1) | DE2137523A1 (enExample) |
| FR (1) | FR2100958B1 (enExample) |
| GB (1) | GB1357733A (enExample) |
| NL (1) | NL7110316A (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0492249A1 (de) * | 1990-12-22 | 1992-07-01 | Bayer Ag | Verwendung von substituierten 1,2,4-Oxadiazolderivaten zur Bekämpfung von Endoparasiten, neue substituierte 1,2,4-Oxadiazolderivate und Verfahren zu ihrer Herstellung |
| WO1995019354A1 (de) * | 1994-01-17 | 1995-07-20 | Bayer Aktiengesellschaft | 3-aryl-alkenyl-1,2,4-oxadiazol-derivate und ihre verwendung zur bekämpfung von tierischen schädlingen |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1397073A (en) * | 1971-05-19 | 1975-06-11 | Glaxo Lab Ltd | 1,2,4-oxadizoles |
-
1970
- 1970-07-28 GB GB1227270A patent/GB1357733A/en not_active Expired
-
1971
- 1971-07-27 CH CH1107071A patent/CH579544A5/xx not_active IP Right Cessation
- 1971-07-27 FR FR7127409A patent/FR2100958B1/fr not_active Expired
- 1971-07-27 NL NL7110316A patent/NL7110316A/xx unknown
- 1971-07-27 DE DE19712137523 patent/DE2137523A1/de active Pending
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0492249A1 (de) * | 1990-12-22 | 1992-07-01 | Bayer Ag | Verwendung von substituierten 1,2,4-Oxadiazolderivaten zur Bekämpfung von Endoparasiten, neue substituierte 1,2,4-Oxadiazolderivate und Verfahren zu ihrer Herstellung |
| AU649086B2 (en) * | 1990-12-22 | 1994-05-12 | Bayer Animal Health Gmbh | Use of substituted 1,2,4-oxadiazole derivatives for combating endoparasites, new substituted 1,2,4-oxadiazole derivatives, and processes for their preparation |
| US5371231A (en) * | 1990-12-22 | 1994-12-06 | Bayer Aktiengesellschaft | Substituted 1,2,4-oxadiazole derivatives |
| US5585493A (en) * | 1990-12-22 | 1996-12-17 | Bayer Aktiengesellschaft | Use of substituted 1,2,4-oxadiazole derivatives for combating endoparasites, new substituted 1,2,4-oxadiazole derivatives, and processes for their preparation |
| WO1995019354A1 (de) * | 1994-01-17 | 1995-07-20 | Bayer Aktiengesellschaft | 3-aryl-alkenyl-1,2,4-oxadiazol-derivate und ihre verwendung zur bekämpfung von tierischen schädlingen |
| AU698783B2 (en) * | 1994-01-17 | 1998-11-05 | Bayer Aktiengesellschaft | 3-aryl-alkenyl-1,2,4-oxadiazole derivatives and their use for combating animal pests |
Also Published As
| Publication number | Publication date |
|---|---|
| CH579544A5 (enExample) | 1976-09-15 |
| FR2100958A1 (enExample) | 1972-03-24 |
| NL7110316A (enExample) | 1972-02-01 |
| FR2100958B1 (enExample) | 1974-10-18 |
| DE2137523A1 (de) | 1972-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1170188A (en) | N-trityl-imidazoles and salts and uses thereof | |
| GB1345880A (en) | Pyridazine derivatives | |
| GB1454778A (en) | Therapeutic compositions comprising dioxamates | |
| GB1351501A (en) | Adenosine derivatives and the production thereof | |
| GB1499760A (en) | Alkyl amino-glucopyranosides | |
| GB1296561A (enExample) | ||
| GB1290818A (enExample) | ||
| GB1236467A (en) | Benzothiazepine derivatives | |
| GB1357733A (en) | 1,2,4-oxadiazole derivatives | |
| GB1153424A (en) | Pharmaceutical Compositions | |
| GB1195199A (en) | Improvements in Compositions comprising Insulin. | |
| GB1212454A (en) | N,n'-substituted formamidines | |
| GB1268956A (en) | Derivatives of 2-(halophenoxy or halophenylthio) alkanamides and their preparation | |
| GB1144875A (en) | Improvements in and relating to pharmacologically-active guanidine derivatives | |
| GB1256723A (enExample) | ||
| ES343314A1 (es) | Procedimiento para la obtencion de derivados de nitrofuranode antimicrobiana. | |
| GB1407856A (en) | Anti-inflammatory thiazole compositions and methods for using same | |
| GB1518042A (en) | Oxadiazolinone derivatives | |
| GB1413454A (en) | 4-alkoxyalkyleneoxy-5-benzylpyrimidines their preparation and pharmaceutical compositions thereof | |
| GB1290841A (enExample) | ||
| ES373909A1 (es) | Procedimiento para la preparacion de quinazolinas. | |
| GB1337506A (en) | Oxobenzofuran carboxamide anti-inflammatory agents | |
| GB1354734A (en) | Pharmaceutical compositions comprising aminoguanidine derivatives | |
| GB1514225A (en) | Paracetamol derivatives | |
| GB1246117A (en) | Pharmaceutical preparations containing glucose compounds, glucose derivatives and process for their manufacture |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PLNP | Patent lapsed through nonpayment of renewal fees |